Champions Oncology, Inc. - stock earnings

CSBR Quarterly earnings

DateEarningsRevenue
2023Q1 -2.4 million USD 12.8 million USD
2022Q4 -16000 USD 14.3 million USD
2022Q3 -319000 USD 13.7 million USD
2022Q2 -344000 USD 12.9 million USD
2022Q1 787000 USD 13.2 million USD
2021Q4 277000 USD 11.8 million USD
2021Q3 -172000 USD 11.3 million USD
2021Q2 -454000 USD 10.6 million USD
2021Q1 740000 USD 10.8 million USD
2020Q4 1000 USD 10.1 million USD
2020Q3 75000 USD 9.5 million USD
2020Q2 -2.0 million USD 8.7 million USD

CSBR Yearly earnings

DateEarningsRevenue
2023 -5.3 million USD 53.9 million USD
2022 548000 USD 49.1 million USD
2021 362000 USD 41.0 million USD
2020 -2.0 million USD 32.1 million USD
2019 128000 USD 27.1 million USD
2018 -1.5 million USD 20.2 million USD
2017 -6.9 million USD 15.4 million USD
2016 -10.4 million USD 11.2 million USD
2015 -13.1 million USD 8.9 million USD
2014 -7.4 million USD 11.6 million USD
2013 -6.4 million USD 8.3 million USD
2012 -8.7 million USD 7.1 million USD
2011 -3.8 million USD 6.9 million USD
2010 -2.9 million USD 4.9 million USD
2009 -2.2 million USD 3.7 million USD
2008 35698 USD 1.4 million USD
2007 -170058 USD ? USD
2006 -303718 USD ? USD
2005 -246544 USD 1.8 million USD
2004 -107687 USD 2.0 million USD
2003 -145994 USD 2.0 million USD
2002 -147312 USD 2.1 million USD
2001 -676883 USD 2.2 million USD
2000 51512 USD 2.2 million USD
1999 20000 USD 2.2 million USD
1998 360000 USD 2.3 million USD
1997 290000 USD 2.2 million USD
1996 50000 USD 2.1 million USD

CSBR

Price: $4.80

52 week price:
4.17
7.32

Earnings Per Share: -0.72 USD

P/E Ratio: -8.55

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 4300

Ebitda: -4.7 million

Market Capitalization: 67.7 million

Links: